SPONSOR
Everest Medicines (China) Co.,Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Primary Membranous NephropathyMinimal Change Disease (MCD)IgA Nephropathy (IgAN)Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Primary Membranous Nephropathy, Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS).
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Everest Medicines (China) Co.,Ltd.
How many clinical trials has Everest Medicines (China) Co.,Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Everest Medicines (China) Co.,Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Primary Membranous Nephropathy, Minimal Change Disease (MCD), IgA Nephropathy (IgAN). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Everest Medicines (China) Co.,Ltd. research focus on?
Everest Medicines (China) Co.,Ltd. clinical trials span Primary Membranous Nephropathy, Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS). The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Everest Medicines (China) Co.,Ltd. clinical trial?
To participate in a Everest Medicines (China) Co.,Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Everest Medicines (China) Co.,Ltd. trials with current recruitment status updated daily.
Clinical Trials by Everest Medicines (China) Co.,Ltd.
NCT05800873 Phase 1
Recruiting
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
Primary Membranous Nephropathy
NCT07614477 Phase 2
Recruiting
Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
Minimal Change Disease (MCD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology